An International Journal of Otorhinolaryngology Clinics

Register      Login

VOLUME 13 , ISSUE 2 ( May-August, 2021 ) > List of Articles

CASE REPORT

Isolated Primary Laryngeal Amyloidosis: A Case Series of a Rare Presentation of Change in Voice

Anmol Wadhwa, Bhavika Verma, Yogesh G Dabholkar

Keywords : Amyloidosis, Hoarseness of voice, Laryngeal

Citation Information : Wadhwa A, Verma B, Dabholkar YG. Isolated Primary Laryngeal Amyloidosis: A Case Series of a Rare Presentation of Change in Voice. Int J Otorhinolaryngol Clin 2021; 13 (2):73-75.

DOI: 10.5005/jp-journals-10003-1384

License: CC BY-NC 4.0

Published Online: 20-11-2021

Copyright Statement:  Copyright © 2021; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

Introduction: Amyloidosis is a benign disease which comprises heterogeneous group of disorders that are characterized by accumulation of amyloid proteins in various body organs. Of the various types, laryngeal amyloidosis is a rare disease of unknown etiology. Case report: We report three cases of isolated primary laryngeal amyloidosis who presented with hoarseness of voice as their chief complaint. A diagnosis was made based on histopathology after a thorough clinical and laboratory workup, and the patients responded well to the surgical excision of the growth and to a combination therapy of oral corticosteroids and bortezomib. Conclusion: Laryngeal amyloidosis, though a rare disease, is a common site for isolated amyloid deposits to occur in head and neck regions, and its diagnosis requires a high index of suspicion as well as thorough workup to exclude systemic involvement.


PDF Share
  1. Saleem T, Fatima S, Ghaffar S, et al. Two cases of primary laryngeal amyloidosis. J Pak Med Assoc 2009 Nov;59(11):789–91. PMID: 20361683.
  2. Alaani A, Warfield AT, Pracy JP. Management of laryngeal amyloidosis. J Laryngol Otol 2004;118(4):279–283. DOI: 10.1258/002221504323012021.
  3. Lachman HJ, Hawkins PN. Amyloidosis of the lung. Chron Resp Dis 2006;3(4):203–214. DOI: 10.1177/1479972306070066.
  4. Sonkhya N, Mittal P, Sonkhya D, et al. Localized laryngeal amyloidosis: a case report and review of literature. Global Adv Res J Med Med Sci 2012;1(3):45–48.
  5. Thompson LD, Derringer GA, Wenig BM. Amyloidosis of the larynx: a clinicopathologic study of 11 cases. Mod Pathol 2000;13(5):528–535. DOI: 10.1038/modpathol.3880092.
  6. Lewis JE, Olsen KD, Kurtin PJ, et al. Laryngeal amyloidosis: a clinicopathologic and immunohistochemical review. Otolaryngol Head Neck Surg 1992;106(4):372–377. DOI: 10.1177/019459989210600410.
  7. Behnoud F, Baghbanian N. Isolated laryngeal amyloidosis. Iran J Otorhinolaryngol. 2013;25(70):49-52. PMID: 24303419; PMCID: PMC3846235.
  8. Siddachari RC, Chankar DA, Pramesh CS, et al. Laryngeal amyloidosis. J Otolaryngol 2005;34(1):60–63. DOI: 10.2310/7070.2005.03131.
  9. Wadhwa A, Dabholkar YG, Bhatt BV et.al. Primary diffuse laryngeal amyloidosis, a rare cause of hoarseness of voice. Int J Health Sci Res 2019;9(11):111–114.
  10. Jiang F, Chen J, Liu H, et al. The effect and safety of bortezomib in the treatment of AL amyloidosis: a systematic review and meta-analysis. Indian J Hematol Blood Transfus 2018;34(2):216–226. DOI: 10.1007/s12288-018-0937-x.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.